Assessing the in-vitro effects of anti-PD-L1 (Avelumab) and recombinant human rhIL-15 in CD8 T cell function from HIV infected patients

被引：0

作者：

Goshu, Bruktawit ^{[1
]}

Lane, Clifford ^{[1
]}

Catalfamo, Marta ^{[2
]}

机构：

[1] NIAID, NIH, North Bethesda, MD USA

[2] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA

来源：

JOURNAL OF IMMUNOLOGY | 2019年 / 202卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

72.14

引用

页数：1

共 23 条

[1] Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function
Goshu, Bruktawit A.
Chen, Hui
Moussa, Maha
Cheng, Jie
Catalfamo, Marta
JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (09): : 1540 - 1549
[2] Recombinant human IL-15 (rhlL-15) in combination with anti-PD-L1(Avelumab) in SIV infected rhesus macaques leads to the expansion of a subset of CXCR3+PD1-/low CD8 T cells
Moussa, Maha
Cheng, Jie
Chen, Ping
Chen, Hui
Li, Tong
Qin, Jing
Lifson, Jeffrey D.
Sneller, Michael C.
Krymskaya, Ludmila
Godin, Steven
Lane, Clifford
Catalfamo, Marta
JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
[3] Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques
Chen, Ping
Chen, Hui
Moussa, Maha
Cheng, Jie
Li, Tong
Qin, Jing
Lifson, Jeffrey D.
Sneller, Michael C.
Krymskaya, Ludmila
Godin, Steven
Lane, H. Clifford
Catalfamo, Marta
JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (04): : 523 - 533
[4] CD38 blockade overcomes the immune resistance to anti-PD-L1 therapy by boosting CD8 T cell response
Chen, Limo
Diao, Lixia
Yang, Yongbin
Yi, Xiaohui
Rodriguez, Jaime
Fan, Youhong
Rodriguez, Leticia
Fradette, Jared
Ungewiss, Christin
Roybal, Jonothan
Zhu, Jingfen
Wang, Jing
Byers, Lauren
Ullrich, Stephen
Wistuba, Ignacio
Heymach, John
Qin, Xiao-Feng
Gibbons, Don
CANCER RESEARCH, 2017, 77
[5] Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
Thibaudin, Marion
Limagne, Emeric
Hampe, Lea
Ballot, Elise
Truntzer, Caroline
Ghiringhelli, Francois
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (10) : 2549 - 2563
[6] Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
Marion Thibaudin
Emeric Limagne
Léa Hampe
Elise Ballot
Caroline Truntzer
Francois Ghiringhelli
Cancer Immunology, Immunotherapy, 2022, 71 : 2549 - 2563
[7] ADMINISTRATION OF INTERLEUKINS 2 AND 18 WITH ANTI-PD-L1 ANTIBODY SUPPRESSES LIVER TUMOR GROWTH BY INCREASING EARLY MEMORY CD8 T CELL NUMBERS
Kimura, Kiminori
Kimura, Masamichi
Kohara, Michinori
Okamura, Haruki
Tanaka, Yoshimasa
HEPATOLOGY, 2023, 78 : S1929 - S1929
[8] Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T Cell Responses to PD-L1 Blockade
Chew, Glen M.
Padua, Ana Joy P.
Chow, Dominic C.
Souza, Scott A.
Clements, Danielle M.
Corley, Michael J.
Pang, Alina P. S.
Alejandria, Marissa M.
Gerschenson, Mariana
Shikuma, Cecilia M.
Ndhlovu, Lishomwa C.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (01) : 24 - 33
[9] Effects of Anti-PD-L1 or IL-15/IL-15Ra-Fc Complex Treatment on CD4-independent CD8+T Cell-Mediated Skin Allograft Rejection
Elzein, Steven
Su, Xiaojun
Zhou, Dawei
Sun, Si
Strahs, Samson Hennessy-
Minze, Laurie
Xiao, Xiang
Li, Xian
AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (01)
[10] Deep sequencing of the t-cell receptors for monitoring peripheral CD8+T cells in advanced NSCLC Chinese patients treated with anti-PD-L1 antibody
Sheng, Jin
Liu, Xiao
Jin, Chao
Xu, Pengfei
Pan, Hong
Shou, Jiawei
Li, Hongsen
Zhou, Xiaoyun
Han, Weidong
Sun, Tao
Fang, Yong
Pan, Hongming
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

← 1 2 3 →